Pleural effusions – integrated management in the context of current guidelines and clinical practice
Authors:
L. Tulinský
Authors‘ workplace:
Katedra chirurgických oborů, LF OU, Ostrava
; Chirurgická klinika LF OU a FN Ostrava
Published in:
Rozhl. Chir., 2025, roč. 104, č. 10, s. 426-433.
Category:
Review
doi:
https://doi.org/10.48095/ccrvch2025426
Overview
Pleural effusions represent a common clinical problem with broad etiological variability encompassing benign, infectious, and malignant causes. Accurate diagnosis, proper classification, and selection of optimal therapeutic intervention in accordance with current guidelines are crucial for successful treatment. This review article summarizes contemporary knowledge in the diagnosis and management of pleural effusions from the thoracic surgery perspective. The management of empyema based on disease stages, therapeutic strategy for malignant effusions with emphasis on lung expandability assessment, and implementation of minimally invasive techniques are discussed in detail. The presented recommendations are derived from recent guidelines of international professional societies (European Respiratory Society, European Society of Thoracic Surgeons, British Thoracic Society) and are supplemented with practical aspects from clinical practice. The aim of this article is to provide readers with a comprehensive tool for effective clinical decision-making in everyday care of patients with various types of pleural effusions.
Keywords:
chest drainage – Pleural effusion – empyema – thoracoscopy – malignant effusion – pleurodesis
Sources
1. Bodtger U, Hallifax RJ. Epidemiology: why is pleural disease becoming more common? In: Maskell NA, Laursen CB, Lee YC (eds). Pleural disease (ERS monograph). Sheffield: European Respiratory Society 2020 : 1–12.
2. Porcel JM, Esquerda A, Vives M et al. Etiology of pleural effusions: analysis of more than 3,000 consecutive thoracenteses. Arch Bronconeumol 2014; 50(5): 161–165. doi: 10.1016/j.arbres.2013.11.007.
3. Porcel JM, Light RW. Pleural fluid analysis: are Light’s criteria still relevant after half a century? Clin Chest Med 2021; 42(4): 599–609. doi: 10.1016/j.ccm.2021.07.003.
4. Light RW, MacGregor MI, Luchsinger PC et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77(4): 507–513. doi: 107326/0003-04819-77-4-507.
5. Lépine PA, Thomas R, Nguyen S et al. Simplified criteria using pleural fluid cholesterol and lactate dehydrogenase to distinguish between exudative and transudative pleural effusions. Respiration 2019; 98(1): 48–54. doi: 10.1159/000496396.
6. Han ZJ, Wu XD, Cheng JJ et al. Diagnostic accuracy of natriuretic peptides for heart failure in patients with pleural effusion: a systematic review and updated meta--analysis. PLoS One 2015; 10(8): e0134376. doi: 10.1371/journal.pone.0134376.
7. Macha DB, Thomas J, Nelson RC. Pigtail catheters used for percutaneous fluid drainage: comparison of performance characteristics. Radiology 2006; 238(3): 1057–1063. doi: 10.1148/radiol.2383050578.
8. Cargill TN, Hassan M, Corcoran JP et al. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J 2019; 54(3): 1900541. doi: 10.1183/13993003.00541-2019.
9. Lai SW, Lin CL, Liao KF. Population-based cohort study investigating the correlation of diabetes mellitus with pleural empyema in adults in Taiwan. Medicine (Baltimore) 2017; 96(36): e7763. doi: 10.1097/MD.0000000000007763.
10. Arnold DT, Hamilton FW, Morris TT et al. Epidemiology of pleural empyema in English hospitals and the impact of influenza. Eur Respir J 2021; 57(6): 2003546. doi: 10.1183/13993003.03546-2020.
11. Rahman NM, Maskell NA, West A et al. Intrapleural use of tissue plasminogen activator and DNase in pleural infections. N Eng J Med 2011; 365(6): 518–526. doi: 10.1056/NEJMoa1012740.
12. Mummadi SR, Stoller JK, Lopez R et al. Epidemiology of adult pleural disease in the United States. Chest 2021; 160(4): 1534–1551. doi: 10.1016/j.chest.2021.05.026.
13. Bobbio A, Bouam S, Frenkiel J et al. Epidemiology and prognostic factors of pleural empyema. Thorax 2021; 76(11): 1117–1123. doi: 10.1136/thoraxjnl-2020-215267.
14. Chalmers JD, Singanayagam A, Murray MP et al. Risk factors for complicated parapneumonic effusion and empyema on presentation to hospital with community-acquired pneumonia. Thorax 2009; 64(7): 592–597. doi: 10.1136/thx.2008.105080.
15. Kim BY, Oh BS, Jang WC et al. Video-assisted thoracoscopic decortication for management of postpneumonic pleural empyema. Am J Surg 2004; 188(3): 321–324. doi: 10.1016/j.amjsurg.2004.06.009.
16. Cargill TN, Hassan M, Corcoran JP et al. A systematic review of comorbidities and outcomes of adult patients with pleural infection. Eur Respir J 2019; 54(3): 1900541. doi: 10.1183/13993003.00541-2019.
17. Bender JM, Ampofo K, Sheng X et al. Parapneumonic empyema deaths during past century, Utah. Emerg Infect Dis 2009; 15(1): 44–48. doi: 10.3201/eid1501.080618.
18. Rathore SS, Hussain N, Manju AH et al. Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: a systematic review and meta-analysis. J Med Virol 2022; 94(1): 229–239. doi: 10.1002/jmv.27301.
19. Marchetti G, Arondi S, Baglivo F et al. New insights in the use of pleural ultrasonography for diagnosis and treatment of pleural disease. Clin Respir J 2018; 12(6): 1993–2005. doi: 10.1111/crj.12907.
20. Svigals PZ, Chopra A, Ravenel JG et al. The accuracy of pleural ultrasonography in diagnosing complicated parapneumonic pleural effusions. Thorax 2017; 72(1): 94–95. doi: 10.1136/thoraxjnl-2016-208904.
21. Porcel JM. Chest imaging for the diagnosis of complicated parapneumonic effusions. Curr Opin Pulm Med 2018; 24(4): 398–402. doi: 10.1097/MCP.0000000000000485.
22. Bielsa S, Valencia H, Ruiz-González A et al. Serum C-reactive protein as an adjunct for identifying complicated parapneumonic effusions. Lung 2014; 192(4): 577–581. doi: 10.1007/s00408-014-9606-5.
23. Bedawi EO, Ricciardi S, Hassan M et al. ERS/ESTS statement on the management of pleural infection in adults. Eur Respir J 2023; 61(2): 2201062. doi: 10.1183/13993003.01062-2022.
24. Teixeira LR, Sasse SA, Villarino MA et al. Antibiotic levels in empyemic pleural fluid. Chest 2000; 117(6): 1734–1739. doi: 10.1378/chest.117.6.1734.
25. Davies HE, Davies RJ, Davies CW et al. Management of pleural infection in adults: British Thoracic Society pleural disease guideline 2010. Thorax 2010; 65(Suppl 2): ii41–ii53. doi: 10.1136/thx.2010.137000.
26. Birkenkamp K, O’Horo JC, Kashyap R et al. Empyema management: a cohort study evaluating antimicrobial therapy. J Infect 2016; 72(5): 537–543. doi: 10.1016/j.jinf.2016.02.009.
27. Porcel JM, Ferreiro L, Rumi L et al. Two vs. three weeks of treatment with amoxicillin-clavulanate for stabilized community-acquired complicated parapneumonic effusions. A preliminary non-inferiority, double-blind, randomized, controlled trial. Pleura Peritoneum 2020; 5(1): 20190027. doi: 10.1515/pp-2019-0027.
28. Towe CW, Srinivasan S, Ho VP et al. Antibiotic resistance is associated with morbidity and mortality after decortication for empyema. Ann Thorac Surg 2021; 111(1): 206–213. doi: 10.1016/j.athoracsur.2020.06.056.
29. Iversen K, Ihlemann N, Gill SU et al. Partial oral versus intravenous antibiotic treatment of endocarditis. N Engl J Med 2019; 380(5): 415–424. doi: 10.1056/NEJMoa1808312.
30. Skouras V, Boultadakis E, Nikoulis D et al. Prognostic value of C-reactive protein in parapneumonic effusions. Respirology 2012; 17(2): 308–314. doi: 10.1111/j.1440-1843.2011.02078.x.
31. Carboni GL, Fahrner R, Gazdhar A et al. Comparison of procalcitonin and CrP in the postoperative course after lung decortication. Eur J Cardiothorac Surg 2008; 33(5): 777–780. doi: 10.1016/j.ejcts.2008.02.013.
32. Maskell NA, Davies CW, Nunn AJ et al. U.K. controlled trial of intrapleural streptokinase for pleural infection. N Engl J Med 2005; 352(9): 865–874. doi: 10.1056/NEJMoa042473.
33. Rahman NM, Maskell NA, Davies CW et al. The relationship between chest tube size and clinical outcome in pleural infection. Chest 2010; 137(3): 536–543. doi: 10.1378/chest.09-1044.
34. Moffett BK, Panchabhai TS, Anaya E et al. Computed tomography measurements of parapneumonic effusion indicative of thoracentesis. Eur Respir J 2011; 38(6): 1406–1411. doi: 10.1183/09031936.00004511.
35. Porcel JM, Valencia H, Bielsa S. Adult patients with parapneumonic empyema who may not require pleural drainage. Rev Clin Esp (Barc) 2016; 216(3): 172–174. doi: 10.1016/j.rce.2016.01.001.
36. Alemán C, Porcel JM, Alegre J et al. Intrapleural fibrinolysis with urokinase versus alteplase in complicated parapneumonic pleural effusions and empyemas: a prospective randomized study. Lung 2015; 193(6): 993–1000. doi: 10.1007/s00408-015-9807-6.
37. Altmann ES, Crossingham I, Wilson S et al. Intra-pleural fibrinolytic therapy versus placebo, or a different fibrinolytic agent, in the treatment of adult parapneumonic effusions and empyema. Cochrane Database Syst Rev 2019; 2019(10): CD002312. doi: 10.1002/14651858.CD002312.pub4.
38. Popowicz N, Bintcliffe O, De Fonseka D et al. Dose de-escalation of intrapleural tissue plasminogen activator therapy for pleural infection. The alteplase dose assessment for pleural infection therapy project. Ann Am Thorac Soc 2017; 14(6): 929–936. doi: 10.1513/AnnalsATS.201609-673OC.
39. Piccolo F, Pitman N, Bhatnagar R et al. Intrapleural tissue plasminogen activator and deoxyribonuclease for pleural infection. An effective and safe alternative to surgery. Ann Am Thorac Soc 2014; 11(9): 1419–1425. doi: 10.1513/AnnalsATS.201407-329OC.
40. Hooper CE, Edey AJ, Wallis A et al. Pleural irrigation trial (PIT): a randomised controlled trial of pleural irrigation with normal saline versus standard care in patients with pleural infection. Eur Respir J 2015; 46(2): 456–463. doi: 10.1183/09031936.00147214.
41. Guinde J, Laroumagne S, Chollet B et al. Saline lavage for the management of severe pleural empyema: a cohort study. Clin Respir J 2021; 15(10): 1097–1103. doi: 10.1111/crj.13415.
42. Porcel JM, Valencia H, Bielsa S. Manual intrapleural saline flushing plus urokinase: a potentially useful therapy for complicated parapneumonic effusions and empyemas. Lung 2017; 195(1): 135–138. doi: 10.1007/s00408-016-9964-2.
43. Ueno T, Toyooka S, Soh J et al. Intrathoracic irrigation with arbekacin for methicillin-resistant Staphylococcus aureus empyema following lung resection. Interact Cardiovasc Thorac Surg 2012; 15(3): 437–441. doi: 10.1093/icvts/ivs285.
44. Bhatnagar R, Skouras VS, Rahman NM et al. Antibiotics for pleural infections. In: Aliberti S, Chalmers JD, Pletz MW (eds). Anti-infectives and the lung (ERS monograph). Sheffield: European Respiratory Society 2017 : 253–263.
45. Wait MA, Sharma S, Hohn J et al. A randomized trial of empyema therapy. Chest 1997; 111(6): 1548–1551. doi: 10.1378/chest.111.6.1548.
46. Höfken H, Herrmann D, Ewig S et al. Video-assisted thoracoscopic surgery of parapneumonic empyema – a 10-year single-centre experience. Pneumologie 2018; 72(12): 843–850. doi: 10.1055/a-0648-0145.
47. Chambers A, Routledge T, Dunning J et al. Is video-assisted thoracoscopic surgical decortication superior to open surgery in the management of adults with primary empyema? Interact Cardiovasc Thorac Surg 2010; 11(2): 171–177. doi: 10.1510/icvts.2010.240408.
48. Chung JH, Lee SH, Kim KT et al. Optimal timing of thoracoscopic drainage and decortication for empyema. Ann Thorac Surg 2014; 97(1): 224–229. doi: 10.1016/j.athoracsur.2013.08.039.
49. Rzyman W, Skokowski J, Romanowicz G et al. Decortication in chronic pleural empyema – effect on lung function. Eur J Cardiothorac Surg 2002; 21(3): 502–507. doi: 10.1016/s1010-7940(01)01167-8.
50. Sanabria A, Valdivieso E, Gomez G et al. Prophylactic antibiotics in chest trauma: a meta-analysis of high-quality studies. World J Surg 2006; 30(10): 1843–1847. doi: 10.1007/s00268-005-0672-y.
51. Morales Uribe CH, Villegas Lanau MI, Petro Sánchez RD. Best timing for thoracoscopic evacuation of retained post-traumatic hemothorax. Surg Endosc 2008; 22(1): 91–95. doi: 10.1007/s00464-007-9378-6.
52. Sziklavari Z, Grosser C, Neu R et al. Complex pleural empyema can be safely treated with vacuum-assisted closure. J Cardiothorac Surg 2011; 6 : 130. doi: 10.1186/1749-8090-6-130.
53. Botianu PV, Dobrica AC, Butiurca A et al. Complex space-filling procedures for intrathoracic infections – personal experience with 76 consecutive cases. Eur J Cardiothorac Surg 2010; 37(2): 478–481. doi: 10.1016/j.ejcts.2009.08.031.
54. Roberts ME, Neville E, Berrisford RG et al. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010. Thorax 2010; 65(Suppl 2): ii32–ii40. doi: 10.1136/thx.2010.136994.
55. Feller-Kopman D, Light R. Pleural disease. N Engl J Med 2018; 378(8): 740–751. doi: 10.1056/NEJMra1403503.
56. Maldonado F, Hawkins FJ, Daniels CE et al. Pleural fluid characteristics of chylothorax. Mayo Clin Proc 2009; 84(2): 129–133. doi: 10.4065/84.2.129.
57. Shiroshita A, Nozaki S, Tanaka Y et al. Thoracic ultrasound for malignant pleural effusion: a systematic review and meta-analysis. ERJ Open Res 2020; 6(4): 00464–2020. doi: 10.1183/23120541.00464-2020.
58. Dixon G, de Fonseka D, Maskell N. Pleural controversies: image guided biopsy vs. thoracoscopy for undiagnosed pleural effusions? J Thorac Dis. 2015; 7(6): 1041–1051. doi: 10.3978/j.issn.2072-1439.2015.01.36.
59. Feller-Kopman DJ, Reddy CB, DeCamp MM et al. Management of malignant pleural effusions. An official ATS/STS/STR clinical practice guideline. Am J Respir Crit Care Med 2018; 198(7): 839–849. doi: 10.1164/rccm.201807-1415ST.
60. Davies HE, Mishra EK, Kahan BC et al. Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial. JAMA 2012; 307(22): 2383–2389.
Labels
Surgery Orthopaedics Trauma surgeryArticle was published in
Perspectives in Surgery
2025 Issue 10
- Metamizole at a Glance and in Practice – Effective Non-Opioid Analgesic for All Ages
- Spasmolytic Effect of Metamizole
- Metamizole vs. Tramadol in Postoperative Analgesia
Most read in this issue
- Management of peripheral nerve injuries
- Pleural effusions – integrated management in the context of current guidelines and clinical practice
- Comparing the use of the Medela Thopaz+ digital drainage system and conventional thoracic drainage techniques in lung resections for cancer
- Chirurgie na průsečíku generací